Safety and Efficacy of IB-FOLFIRI in BRAF V600E-Mutant Metastatic Colorectal Cancer

NCT07150247 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

BRAF V600 Colorectal Cancer

Interventions

DRUG: Iparomlimab and Tuvonralimab
DRUG: Bevacizumab
DRUG: 5-Fluorouracil
DRUG: Irinotecan (drug)

Sponsor

Sun Yat-sen University